India says 3 militants behind Kashmir shooting that sparked tensions with Pakistan have been killed
Amit Shah said the three men were Pakistani nationals who were killed in a joint operation by the military, paramilitary and police Monday on the outskirts of Kashmir's main city of Srinagar. Shah made the remarks in India's lower house of the parliament, and The Associated Press couldn't independently verify the details.
Shah said the bodies of the men were identified by people who had provided food and shelter to them before they carried out the massacre in April. He cited a forensic report and said the rifle cartridges found at Monday's gunbattle site matched those used during the attack.
The April gun massacre killed 26 people, mostly Hindu tourists. New Delhi blamed the attack on Pakistan, which denied responsibility while calling for a neutral investigation.
It led to tit-for-tat military strikes by India and Pakistan that brought the nuclear-armed rivals to the brink of their third war over the region. Dozens of people were killed on both sides until a ceasefire was reached on May 10 after U.S. mediation.
The four-day fighting between the nuclear-armed rivals was their worst in decades.
Before the April gun massacre in the Kashmiri resort town of Pahalgam, fighting had largely ebbed in the region's Kashmir Valley, the heartland of anti-India rebellion and mainly shifted to mountainous areas of Jammu in the last few years.
India and Pakistan each administer part of Kashmir, but both claim the Himalayan territory in its entirety. Militants in the Indian-controlled portion of Kashmir have been fighting New Delhi's rule since 1989.
India describes militancy in Kashmir as Pakistan-backed terrorism. Pakistan denies it.
Many Muslim Kashmiris support the rebels' goal of uniting the territory, either under Pakistani rule or as an independent country. Tens of thousands of civilians, rebels and government forces have been killed in the conflict.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
42 minutes ago
- San Francisco Chronicle
Trump attacks Charlamagne Tha God after radio host criticizes his presidency
WASHINGTON (AP) — President Donald Trump on Sunday lashed out at radio host Charlamagne Tha God, saying in a social media post that the popular broadcaster "knows nothing about me or what I have done.' Trump's comments came a day after Charlamagne, whose real name is Lenard McKelvey, criticized Trump on a Fox News show hosted by Lara Trump, the president's daughter-in-law and former co-chair of the Republican National Committee. Asked how he would rate Trump's presidency, the radio host said, 'I wouldn't give it a good rating simply because the least of us are still being impacted the worst.' Trump said on Truth Social that Charlamagne was a 'dope' who voted for Democratic Vice President Kamala Harris. Charlamagne said he personally will benefit from tax breaks approved in Trump's tax-and spending law, but said, 'There's going to be so many people that's hurt by that bill.'' 'Anything that takes away Medicaid from people and will put people in a worse financial situation than they were previously in, I'm not for," he added. Charlamagne also predicted that 'traditional conservatives" are going to take back the Republican Party from Trump's Make America Great Again movement, citing controversy over Trump's refusal to release files related to disgraced financier and convicted sex offender Jeffrey Epstein. 'I think there's a political coup going on right now in the Republican Party that people aren't paying attention to,' Charlamagne said. 'I think this Epstein thing is going to be a way for traditional conservatives to take their party back. I really do. I think that they know this is the issue that has gotten the base riled up, the MAGA base isn't letting this issue go and for the first time they can probably take their party back and not piss off the MAGA base. I think they're going to do that.' The Epstein case has dominated news coverage in recent weeks after the Justice Department said it will not be releasing any additional documents from the Epstein sex trafficking investigation. The decision has infuriated online sleuths, conspiracy theorists and elements of Trump's base who had hoped to see proof of a government cover-up. Officials have said Epstein killed himself in his New York jail cell while awaiting trial in 2019, but his case has generated endless attention and conspiracy theories because of his links to famous people, including Trump and other billionaires. 'Can anyone imagine the uproar there would be if I used that nickname?' Trump asked. Charlamagne told Lara Trump that his criticism of the Republican president was not new, adding that he 'gave President Biden the same hell' when he didn't think the Democrat was doing a good job.
Politico
an hour ago
- Politico
Texas Dems to flee state amid national redistricting battle
They will head to Illinois, where Gov. JB Pritzker has expressed sympathy for their plight. A map of Congressional Districts proposed plan is seen a Texas legislators' public hearing on redistricting in Austin on Aug. 1, 2025. | Eric Gay/AP By Adam Wren 08/03/2025 03:57 PM EDT Dozens of Texas Democrats plan to flee the state amid a special session Sunday afternoon, making a last-ditch effort to disrupt a mid-decade redistricting attempt forced by President Donald Trump, according to one person briefed on the matter. It marks their second act of breaking quorum — when the state House will lack the minimum number of lawmakers needed to conduct business — since 2021. And it comes as the party scrambles to counter the aggressive action in Texas, intended to keep Republicans in power in Congress next year by creating five GOP-friendly seats in the state. Four years ago, Republican Texas Gov. Greg Abbott called for the arrest of fleeing lawmakers upon their return to their state.
New York Post
2 hours ago
- New York Post
Beyond Trump's trade deals, consolation for the little guy and other commentary
Business desk: Beyond Trump's Trade Deals 'Dealmaker-In-Chief' Donald Trump has been 'positively monomaniacal' about trade lately, marvels Freddy Gray at The Spectator. His 'real coup' is the 'new framework arrangement with the European Union,' which is 'not simply a major breakthrough in and of itself,' but also 'a useful piece of leverage in the even bigger tariff struggle with China' — because it pulls 'Europe more towards a western trading orbit and less towards the east.' Trump then slammed India for 'buying up Russian oil and gas,' and pivoted sharply by praising a new deal with Pakistan, 'including an arrangement to invest in Pakistani oil.' Advertisement Meanwhile, his enthusiasm for Pakistan — 'an extension of China's empire' — may be part of a plan to 'ring loud alarm bells' in Beijing. From the right: Consolation for the Little Guy 'For all the political criticism they take, the federal courts keep delivering good outcomes more often than not,' cheers The Wall Street Journal's Editorial Board. In 2016, the Labor Department 'imposed hundreds of thousands of dollars in fines' on a fourth-generation farm, Sun Valley Orchards — first requesting penalties and then approving them itself, thus 'serving as prosecutor, judge and jury.' Advertisement But an appeals court just ruled the proceedings 'should properly be enforced in federal court' — the proper venues for federal agencies to impose fines. Sun Valley has since gone out of business,' but at least its owners 'have the consolation of a ruling that will vindicate the rights of other farmers and small businesses under the boot heel of the bureaucracy.' Libertarian: Get Honest About Gov't Spending 'What kind of government do Americans want seriously enough to pay for?' asks Veronique de Rugy at Reason. 'I suspect that most people aren't willing to pay the taxes required to fund everything our current government does.' Advertisement Yet 'all the benefits and subsidies that we're unwilling to pay for' but keep going 'will eventually have to be paid for in the future with higher taxes, inflation, or both' by our children and grandchildren. 'Growing the economy' can be 'part of the solution,' but it won't be enough, and 'raising taxes on the rich will fall short too,' since higher tax rates 'do not automatically translate to more tax revenue.' 'It's long past time' we 'ask what level of spending we truly want with the money we truly have.' Get opinions and commentary from our columnists Subscribe to our daily Post Opinion newsletter! Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters Liberal: Hey, Dems — End the #Resistance Advertisement 'Nonstop Democratic fulminations in Trump's second term have been notably unsuccessful in resuscitating the party's toxic brand,' sighs the Liberal Patriot's Ruy Teixeira. Tellingly, 'voters, despite their negative views of Trump's performance on key issues, still prefer Republicans to Democrats.' Also, 'voters neither like nor trust' Dems, and thus don't see them as 'an obvious choice over their opponents.' Yet 'many Democratic politicians persist in reading — loudly — from the #Resistance script.' Why? The '#Resistance trope is what advantages individual Democratic politicians within the party because it generates adulation from activists, media coverage, and gushers of donations.' And taking back the House in 2026 will only 'convince #Resistance aficionados that nothing really needs to change.' Hello, President JD Vance. Health beat: Big Pharma Wins, Patients Lose 'In May, Dr. Vinay Prasad joined the Food & Drug Administration as the top regulator for vaccines,' yet he 'apparently knew the games too well,' gripes Alex Berensen at his Substack: After last week's attacks from Trump's allies, Prasad resigned: 'He was targeted because he posed a direct threat to Big Pharma profits.' Advertisement Just last month, he told Sarepta Therapeutics 'it needed to halt shipments of its gene therapy for Duchenne muscular dystrophy, or DMD.' 'Sarepta has never shown its drugs actually benefit patients.' The company won the right to a drug trial in 2016; 'nine years later, Sarepta still hasn't completed those trials.' Yet 'that hasn't stopped it from selling the drug — for up to $1.5 million per year.' Advertisement 'Big Pharma scalped Prasad for his honesty.' — Compiled by The Post Editorial Board
